A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)

Name: A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
License: Public Domain

Alkahest, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetic retinopathy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 463663
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.